SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717 

SEC Filings

Filing date Form Description Filing Group View
425

Filing of certain prospectuses and communications in connection with business combination transactions

Other
View HTML
425

Filing of certain prospectuses and communications in connection with business combination transactions

Other
View HTML
425

Filing of certain prospectuses and communications in connection with business combination transactions

Other
View HTML
425

Filing of certain prospectuses and communications in connection with business combination transactions

Other
View HTML
425

Filing of certain prospectuses and communications in connection with business combination transactions

Other
View HTML
425

Filing of certain prospectuses and communications in connection with business combination transactions

Other
View HTML
425

Filing of certain prospectuses and communications in connection with business combination transactions

Other
View HTML
SC 13D

Filing by person(s) reporting owned shares of common stock in a public company >5%

Other
View HTML
SC 13D

Filing by person(s) reporting owned shares of common stock in a public company >5%

Other
View HTML
SC 13D

Filing by person(s) reporting owned shares of common stock in a public company >5%

Other
View HTML

Data provided by Kaleidoscope.